130 related articles for article (PubMed ID: 19223175)
1. Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent.
Lorusso G; Vannini N; Sogno I; Generoso L; Garbisa S; Noonan DM; Albini A
Eur J Cancer; 2009 May; 45(8):1474-84. PubMed ID: 19223175
[TBL] [Abstract][Full Text] [Related]
2. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
Martínez-Poveda B; Quesada AR; Medina MA
Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212
[TBL] [Abstract][Full Text] [Related]
3. Hyperforin acts as an angiogenesis inhibitor.
Schempp CM; Kiss J; Kirkin V; Averbeck M; Simon-Haarhaus B; Kremer B; Termeer CC; Sleeman J; Simon JC
Planta Med; 2005 Nov; 71(11):999-1004. PubMed ID: 16320199
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis.
Martínez-Poveda B; Verotta L; Bombardelli E; Quesada AR; Medina MA
PLoS One; 2010 Mar; 5(3):e9558. PubMed ID: 20224821
[TBL] [Abstract][Full Text] [Related]
5. Potential antidepressant properties of IDN 5491 (hyperforin-trimethoxybenzoate), a semisynthetic ester of hyperforin.
Cervo L; Mennini T; Rozio M; Ekalle-Soppo CB; Canetta A; Burbassi S; Guiso G; Pirona L; Riva A; Morazzoni P; Caccia S; Gobbi M
Eur Neuropsychopharmacol; 2005 Mar; 15(2):211-8. PubMed ID: 15695067
[TBL] [Abstract][Full Text] [Related]
6. Hyperforin and aristoforin inhibit lymphatic endothelial cell proliferation in vitro and suppress tumor-induced lymphangiogenesis in vivo.
Rothley M; Schmid A; Thiele W; Schacht V; Plaumann D; Gartner M; Yektaoglu A; Bruyère F; Noël A; Giannis A; Sleeman JP
Int J Cancer; 2009 Jul; 125(1):34-42. PubMed ID: 19326439
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into the antileukemic activity of hyperforin.
Billard C; Merhi F; Bauvois B
Curr Cancer Drug Targets; 2013 Jan; 13(1):1-10. PubMed ID: 22924417
[TBL] [Abstract][Full Text] [Related]
8. Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis.
Dell'Aica I; Niero R; Piazza F; Cabrelle A; Sartor L; Colalto C; Brunetta E; Lorusso G; Benelli R; Albini A; Calabrese F; Agostini C; Garbisa S
J Pharmacol Exp Ther; 2007 May; 321(2):492-500. PubMed ID: 17289834
[TBL] [Abstract][Full Text] [Related]
9. Hyperforin: more than an antidepressant bioactive compound?
Medina MA; Martínez-Poveda B; Amores-Sánchez MI; Quesada AR
Life Sci; 2006 Jun; 79(2):105-11. PubMed ID: 16438991
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant hyperforin up-regulates VEGF in CNS tumour cells.
Tassone E; Maran C; Masola V; Bradaschia A; Garbisa S; Onisto M
Pharmacol Res; 2011 Jan; 63(1):37-43. PubMed ID: 20883786
[TBL] [Abstract][Full Text] [Related]
11. Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease.
Cabrelle A; Dell'Aica I; Melchiori L; Carraro S; Brunetta E; Niero R; Scquizzato E; D'Intino G; Calzà L; Garbisa S; Agostini C
J Leukoc Biol; 2008 Jan; 83(1):212-9. PubMed ID: 17947392
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids.
Sogno I; Vannini N; Lorusso G; Cammarota R; Noonan DM; Generoso L; Sporn MB; Albini A
Recent Results Cancer Res; 2009; 181():209-12. PubMed ID: 19213570
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.
Schempp CM; Kirkin V; Simon-Haarhaus B; Kersten A; Kiss J; Termeer CC; Gilb B; Kaufmann T; Borner C; Sleeman JP; Simon JC
Oncogene; 2002 Feb; 21(8):1242-50. PubMed ID: 11850844
[TBL] [Abstract][Full Text] [Related]
14. Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.
Dinamarca MC; Cerpa W; Garrido J; Hancke JL; Inestrosa NC
Mol Psychiatry; 2006 Nov; 11(11):1032-48. PubMed ID: 16880827
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
[TBL] [Abstract][Full Text] [Related]
16. [Examination of different factors influencing the vascularization of human cutaneous melanoma].
Kiss J
Magy Onkol; 2008 Dec; 52(4):385-9. PubMed ID: 19068467
[TBL] [Abstract][Full Text] [Related]
17. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
Bouron A; Lorrain E
Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
[TBL] [Abstract][Full Text] [Related]
18. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
19. The antidepressant mechanism of Hypericum perforatum.
Mennini T; Gobbi M
Life Sci; 2004 Jul; 75(9):1021-7. PubMed ID: 15207650
[TBL] [Abstract][Full Text] [Related]
20. Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts.
Cervo L; Rozio M; Ekalle-Soppo CB; Guiso G; Morazzoni P; Caccia S
Psychopharmacology (Berl); 2002 Dec; 164(4):423-8. PubMed ID: 12457273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
